ACR: Low-Dose Hydroxychloroquine Tied to More Hospitalizations for Lupus Flares
FRIDAY, Nov. 18, 2022 (HealthDay News) — Patients with systemic lupus erythematosus (SLE) who are treated with lower doses of hydroxychloroquine (HCQ) have an increased risk for hospitalizations for SLE flares, according to a study presented at the a…
Learn MoreSleep Deprivation May Increase Risk for Systemic Lupus in Women
THURSDAY, Sept. 22, 2022 (HealthDay News) — Lack of sleep is associated with an increased risk for systemic lupus erythematosus (SLE), particularly among women with concomitant depression or bodily pain, according to a study published online Sept. 12…
Learn MoreEn un pequeño estudio, la terapia de T con RAQ lleva el lupus a la remisión
JUEVES, 15 de septiembre de 2022 (HealthDay News) — Aunque el lupus no tiene cura y los tratamientos no funcionan en muchas de los 1.5 millones de personas que viven con la enfermedad en Estados Unidos, un nuevo estudio muestra que una terapia contra…
Learn MoreIn Small Study, CAR-T Therapy Pushes Lupus Into Remission
THURSDAY, Sept. 15, 2022 (HealthDay News) — While there’s no cure for lupus and treatments don’t work for many of the 1.5 million people who live with the disease in the United States, a new study shows a cancer therapy may kick hard-to-treat lupus i…
Learn MoreLupus, Psoriasis Patients May Face Greater Dangers After Heart Attack
THURSDAY, Sept. 15, 2022 (HealthDay News) — People with autoimmune disorders like lupus, rheumatoid arthritis or psoriasis who suffer a heart attack are more likely to die or develop severe heart-related complications in the aftermath, a new study sh…
Learn MoreUn medicamento experimental se muestra promisorio contra el lupus
JUEVES, 8 de septiembre de 2022 (HealthDay News) — Un medicamento experimental, que se ha demostrado que puede tratar los sarpullidos en las personas con lupus, también podría ayudar con el dolor de las articulaciones relacionados con el lupus.El lup…
Learn MoreReduction in Swollen, Tender Joints Greater With Litifilimab in Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — Patients with systemic lupus erythematosus (SLE) receiving litifilimab, a humanized monoclonal antibody that binds to blood dendritic cell antigen 2, versus placebo have a greater reduction in the number of …
Learn MoreExperimental Drug Shows Promise Against Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.Affecting as many as 1.5 million people in the United States, lupus is an autoimmune …
Learn MoreExperimental Drug Shows Promise Against Lupus
THURSDAY, Sept. 8, 2022 (HealthDay News) — An experimental drug that has been shown to treat rashes in people with lupus may also help with lupus-related joint pain.Affecting as many as 1.5 million people in the United States, lupus is an autoimmune …
Learn MoreLupus, MS and Other Autoimmune Disorders Raise Heart Risks
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing hear…
Learn More